This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Tredegar Q1 Earnings Down Y/Y as Aluminum Costs Weigh on Margins
by Zacks Equity Research
TG's Q1 earnings fall year over year despite a 14% sales rise, as rising aluminum costs and margin pressures impacted profitability, partly offset by strong PE Films gains.
The Zacks Analyst Blog Highlights NVIDIA, Abbott Laboratories, Linde and Tredegar
by Zacks Equity Research
NVIDIA, Abbott Laboratories, Linde and Tredegar are part of the Zacks top Analyst Blog
Top Stock Reports for NVIDIA, Abbott Laboratories & Linde
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Abbott Laboratories (ABT) and Linde plc (LIN), as well as a micro-cap stock Tredegar Corp. (TG).
Tredegar Stock Rises 8% on Narrower Y/Y Loss in Q4, PE Films Unit Aids
by Zacks Equity Research
TG incurs a net loss in Q4, narrowing year over year due to the strong PE Films and Aluminum Extrusions segment, but faces headwinds from supply chain challenges.
Tredegar's Q3 Loss Narrows Y/Y, PE Films Drives Revenue Growth
by Zacks Equity Research
TG posts a narrower year-over-year loss per share in Q3 as revenues rise 9.5% from gains in PE Films and Aluminum Extrusions, despite ongoing margin pressures from competitive and cost challenges.
The Zacks Analyst Blog Highlights Broadcom, Novo Nordisk, ConocoPhillips, Smith-Midland Corp. and Tredegar
by Zacks Equity Research
Broadcom, Novo Nordisk, ConocoPhillips, Smith-Midland Corp. and Tredegar are part of the Zacks top Analyst Blog.
Top Research Reports for Broadcom, Novo Nordisk & ConocoPhillips
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Novo Nordisk A/S (NVO) and ConocoPhillips (COP), as well as two micro-cap stocks Smith-Midland Corp. (SMID) and Tredegar Corp. (TG).
Tredegar (TG) Q2 Earnings Rise Y/Y on Strength of PE Films Unit
by Zacks Equity Research
Tredegar (TG) reports a Q2 net income of 26 cents per share, driven by strategic cost management and operational improvements, marking a significant recovery from a loss in the prior-year quarter.
Zacks Initiates Coverage of Tredegar With Underperform Recommendation
by Debasmita Chatterjee
Discover why Zacks has rated Tredegar as "Underperform," being the first on Wall Street to initiate coverage on the stock. Delve into the challenges posed by volatile material costs, high debt, fierce competition and economic cycles, despite recent financial rebounds and strategic divestments.